Nomi 2.5mg Nasal Spray

✔️ Side Effects

• Dizziness
• Nausea
• Dry mouth
• Drowsiness
• Fatigue or weakness
• Tingling or abnormal sensations (paresthesia)
• Warm or cold sensations
• Heaviness
• Tightness or pressure in the chest, throat, neck, or jaw
• Flushing or a sensation of warmth

✔️ Zolmitriptan should not be used in patients with:

• Ischemic heart disease or a history of myocardial infarction
• Coronary vasospasm
• Previous stroke or transient ischemic attack
• Uncontrolled or severe hypertension
• Wolff-Parkinson-White syndrome or certain accessory conduction pathway arrhythmias
• Basilar or hemiplegic migraine
• Known hypersensitivity to Zolmitriptan
• Concurrent use of another 5-HT1 agonist
• Use of ergotamine or ergot-type medicines within the previous 24 hours
• Recent or concurrent use of monoamine oxidase inhibitors (MAOIs), according to prescribing restrictions

✔️ Precautions & Warnings

Zolmitriptan should only be used when the diagnosis of migraine has been established and other potentially serious neurological conditions have been excluded.

It may cause dizziness or drowsiness. Avoid driving, operating machinery, or performing activities requiring mental alertness until you know how the medicine affects you.

Zolmitriptan may temporarily increase blood pressure. Blood pressure should be monitored, particularly in patients with a history of hypertension.

Seek immediate medical attention if you experience:

• Severe or persistent chest pain or pressure
• Difficulty breathing or wheezing
• Severe allergic reactions or skin rash
• Symptoms suggestive of a serious cardiovascular problem

Contact your doctor if you develop abdominal pain, bloody diarrhea, or worsening hypertension while using this medicine.

Cardiovascular Precautions

Rare but serious cardiovascular reactions, including myocardial infarction, coronary vasospasm, and cardiac arrhythmias, have been reported with triptan therapy.

Patients with risk factors for coronary artery disease may require cardiovascular evaluation before treatment. These risk factors may include hypertension, diabetes, smoking, obesity, high cholesterol, certain age groups, or a family history of coronary artery disease.

Zolmitriptan is contraindicated in patients with established ischemic heart disease, previous myocardial infarction, coronary vasospasm, previous stroke or transient ischemic attack, uncontrolled or severe hypertension, or certain accessory conduction pathway disorders.

✔️ Zolmitriptan may interact with several medicines, including:

• SSRIs and SNRIs: May increase the risk of serotonin syndrome.
• MAO inhibitors and reversible MAO-A inhibitors: May increase Zolmitriptan exposure and the risk of serotonin syndrome. Zolmitriptan should generally not be used during MAOI treatment or within the specified washout period.
• Cimetidine: May increase Zolmitriptan concentrations.
• CYP1A2 inhibitors: May increase Zolmitriptan exposure.
• Other 5-HT1 agonists: Should not be used within 24 hours of Zolmitriptan.
• Ergotamine or ergot-type medicines: May produce additive vasoconstrictive effects and should not be used within 24 hours of Zolmitriptan.

✔️ Storage:

Store according to the manufacturer's instructions and keep the nasal spray protected from excessive heat, moisture, and direct light. Keep out of reach of children.